Incriminating ecig no matter what is becoming a new national sport
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
Quit Strong: New Zealand bets on vaping to quit smoking
QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking
The Smile Study has officially started the operational phase
On 22 July 2020, Smile Study started officially the operational phase of the projects with the training on the equipments and the visiting of first subjects enrolledDr. Elbert Waller of the Inspektor Research Systems has been welcomed in Catania for for the conduction of a training on the latest innovative technologies in dental diagnostic
Do You really know what Tobacco Harm Reduction is?
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
The new Vaping Manual between Science and Real Use
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
Replica Project: the Trip through all the Partners
The Coehar Director, Giovanni Li Volti and the Co-project Leader for Replica, Dr. Massimo Caruso have organized a tour to all the international partners of the project to harmonize the protocols of the study for the first year of the Replica Project
Replica Project Partnership: A Trip to Oman
The Replica Project aim is to replicate the most important studies in the field of Tobacco Harm Reduction (THR)The following video refers to one of the stop of the Replica Tour: Giovanni Li Volti and the Co-project Leader Massimo Caruso were in Oman.
Smoking and COVID-19: hospitalized smokers are far fewer than expected but have more severe disease
A new study published in the journal "Therapeutic Advances in Chronic Disease" provides important insight to the issue of smoking and COVID-19. The number of smokers with severe COVID-19 that requires hospitalization is by far lower than expected based on population smoking rates. The very few smokers who are eventually hospitalized have higher odds for severe disease and adverse outcome.
Smokers, former smokers, never smokers and vapers: a survey by the CoEHAR explains their behavior during the lockdown
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
- Go to the previous page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- …
- 33
- Go to the next page
